Injectable Steroids

Tren MIX 150 mg Body Pharm

Body Pharm

95,00

In Stock (100 available)

Tren MIX 150 mg Body Pharm (150 mg) — Backed by Body Pharm’s commitment to quality, this Trenbolone blend combines multiple esters (typically Acetate, Enanthate, and He…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost

Description

Tren MIX 150 mg Body Pharm — Backed by a rigorous commitment to quality, this Trenbolone blend combines multiple esters (typically Acetate, Enanthate, and Hexahydrobenzylcarbonate) to provide both immediate and prolonged Trenbolone activity. The short-acting acetate delivers rapid onset within hours, while the longer esters maintain elevated blood levels for sustained anabolic and fat-burning effects throughout the cycle. This formulation is dosed at 150 mg per unit.

Key Benefits

  • Multi-ester 19-nor trenbolone — acute kick + sustained coverage
  • Typical mix: acetate + enanthate + hexahydrobenzylcarbonate
  • Injection frequency every 3–4 days sufficient
  • Active molecule identical to single-ester tren at AR level
  • Same side-effect burden as standalone tren — blend isn’t softer
  • Each unit dosed at 150 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 150–300 mg/week split across 2–3 injections. The acetate fraction peaks within a day while longer esters build steady-state over 3–4 weeks. Cycles 10–12 weeks.

How It Works

Blend of trenbolone acetate, enanthate, and hexahydrobenzylcarbonate (parabolan) — all three are 19-nor derivatives with the same extreme AR affinity as single-ester trenbolone. Progestagenic. The blend provides staggered release: acetate in ~24 h, enanthate ~7 days, hexa ~10 days. At the receptor level the active molecule is identical across esters.

Pharmacokinetics

Composite release profile. Faster kick-in than pure enanthate, flatter serum than pure acetate. Injection frequency every 3–4 days adequate. Steady-state in 3–4 weeks.

Potential Side Effects

Identical to single-ester tren: prolactin rise, night sweats, insomnia, CV stress, aggression. Caber 0.25 mg 2×/week mandatory. Bloodwork including prolactin at week 6.

Cycle & Stacking Guide

Cutting and recomp cycles 10–12 weeks. Test E 300–500 mg/week + tren blend 200–300 mg/week. Attention to sleep, resting HR, and lipids throughout. Not for first or second cycles.

Manufacturer Notes

Body Pharm is an established underground-market producer. Vials ship with batch codes; request the accompanying lab report from the distributor before first use.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Tren MIX 150 mg Body Pharm”

Your email address will not be published. Required fields are marked *

Trenbolone Acetate

Physical & Chemical Properties for Research Purposes
Chemical structure of Trenbolone Acetate (C20H24O3) for laboratory analysis
2D structural representation · PubChem CID 24822 ↗
Chemical Identity
# CAS Registry Number 10161-34-9
Σ IUPAC Name [(8S,13S,14S,17S)-13-methyl-3-oxo-2,3,6,7,8,14-hexahydro-1H-cyclopenta[a]phenanthrene-17-yl] acetate
F Molecular Formula C20H24O3
M Molecular Weight 312.41 g/mol
SMILES CC(=O)O[C@@H]1CC[C@@H]2C3=CC=C4CC(=O)CC[C@]4(C)[C@@H]3CC[C@]12C
InChIKey FNYKCQMZFXUVMA-LKBHZCJUSA-N
Melting Point 96-97 °C
Solubility Practically insoluble in water; soluble in oils and organic solvents
Biological Half-life 1 day (IM)
PubChem CID 24822 ↗
Pharmacological Profile
Anabolic Rating 500
Androgenic Rating 500
Aromatization None
Hepatotoxicity Low
Detection Time 5 months

Clinical Notes

19-nor 5alpha-reduced analogue of nandrolone. Non-aromatizable — AR-binding affinity roughly 5x testosterone, with measurable agonist activity at the progesterone receptor. The acetate ester generates fast serum peaks and drops; EOD administration is the floor for stable concentrations. Clinical picture: rapid lean-tissue accretion independent of caloric surplus, reduced adipose mass via direct AR signalling in adipocytes, pronounced lipid shift (HDL suppression 40–60%). Prolactin elevation occurs in a subset — cabergoline 0.25 mg twice weekly is the standard response. Renal biomarkers (creatinine, cystatin C) commonly shift upward; this reflects haem metabolite excretion in urine (brick-red pigment) rather than confirmed nephrotoxicity, but CKD-EPI readings should be interpreted with the confounding documented. Nocturnal sympathetic tone (insomnia, diaphoresis) is dose-dependent and resolves on cessation.

Known trade names: Finajet, Finaplix, Trenbol

Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.